Updated Apr. 2, 2013 at 7:03 a.m.

Premium Lock BioCryst shares rally on possibility of keeping $235M influenza project alive

Published: 2013-04-01 08:14:00
Updated: 2013-04-02 07:03:58

BioCryst BioCryst

BioCryst, which cut half its work force in a cost-cutting move in December, says it will meet with the FDA to dermine ways it might advance the intravenous flue treatment peramivir alive....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll